Latest 10-Q quarterly reports

NASDAQ
Marriott International reported a 12% increase in net fee revenues for Q1 2026, driven by strong franchise fee growth, though net income saw a slight decrease compared to the prior year.
NASDAQ
Rand Capital Corporation's Q1 2026 filing shows a decrease in total assets and net assets, with a notable shift in cash and cash equivalents.
NYSE
Clear Secure, Inc. announced a significant increase in revenue and net income for the first quarter of 2026, driven by strong member growth and strategic pricing adjustments.
NYSE
White Mountains Insurance Group reported a net loss of $27.2 million for Q1 2026, impacted by a decline in MediaAlpha share price and catastrophe losses, despite solid operational performance.
NASDAQ
Twin Disc, Inc. announced a 19% increase in net sales for the third quarter of fiscal year 2026, reaching $96.7 million, driven by strong performance across its manufacturing and distribution segments.
NASDAQ
Taysha Gene Therapies reports increased R&D spending and net loss in Q1 2026, with cash reserves projected to fund operations into 2028.
NASDAQ
One Stop Systems, Inc. announced its first quarter 2026 financial results, showcasing a significant 55% year-over-year revenue increase driven by strong demand in defense and medical sectors.
NYSE
SmartRent, Inc. announced its first quarter 2026 financial results, reporting a 6% decrease in total revenue to $38.7 million, primarily due to lower hardware shipments.
NASDAQ
Veracyte, Inc. announced a significant increase in revenue and net income for the first quarter of 2026, driven by strong performance in its testing business.
NASDAQ
Urogen Pharma Ltd. announced a Second Amended and Restated Loan Agreement, increasing its credit facility to $250 million with BioPharma Credit PLC.
NASDAQ
Trinity Capital Inc. reported a robust Q1 2026 with significant growth in investment income and a diversified portfolio, despite market volatilities.
NYSE
Aflac Incorporated announced a significant increase in net earnings for the first quarter of 2026, largely due to a substantial recovery in net investment gains compared to the prior year.
NASDAQ
Novavax reported a significant revenue decline in Q1 2026, primarily due to lower product sales, but saw a substantial increase in licensing, royalties, and other income, driven by new partnerships and amortization of upfront payments.
NASDAQ
Bioventus Inc. announced its first quarter 2026 financial results, showing a significant increase in net sales and a return to profitability.
NASDAQ
908 Devices Inc. announced its first quarter 2026 financial results, reporting a 14% increase in total revenue to $13.4 million, driven by strong product revenue growth, while net loss from continuing operations widened.
Lucky Strike Entertainment reported a 1% revenue increase for Q3 2026, driven by acquisitions and new openings, but net loss widened due to increased operating costs and interest expenses.
NYSE
Holley Inc. reported a 3.7% decrease in net sales for Q1 2026, but saw a significant surge in net income driven by lower interest expenses and favorable fair value adjustments.
Fiserv reports a 33% year-over-year drop in net income for Q1 2026, driven by increased expenses related to its 'One Fiserv' transformation initiative and a decline in high-margin product revenue.
NASDAQ
Latham Group reported a 5.3% increase in net sales for Q1 2026, driven by organic growth and acquisitions, but experienced a wider net loss.
NYSE
Dine Brands Global reports a slight revenue increase driven by company-owned restaurants, but faces challenges in franchise revenues and increased interest expenses.
NASDAQ
TScan Therapeutics, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing a net loss of $28.7 million and continued investment in its TCR-T therapy pipeline.
NASDAQ
Lifecore Biomedical reported a significant decrease in total revenues for the first quarter of 2026, driven by lower demand in HA manufacturing and CDMO services.
NYSE
SharkNinja reported a 15.6% increase in net sales for Q1 2026, reaching $1.41 billion, driven by strong performance in Cleaning and Cooking appliances, while net income remained stable year-over-year.
NASDAQ
Lineage Inc. reported mixed financial results for Q1 2026, with revenue growth in warehousing offset by a decline in integrated solutions, while net income turned negative.
NYSE
The Brink's Company reported a 10% increase in Q1 2026 revenues to $1.375 billion, driven by currency tailwinds and organic growth across segments, despite a decrease in GAAP operating profit.
NYSE
Centrus Energy Corp. reported a decrease in Q1 2026 revenue driven by lower SWU sales, while Technical Solutions segment revenue increased significantly due to HALEU operations.
NASDAQ
Immunocore Holdings plc announced its first-quarter 2026 financial results, showcasing a 13.6% increase in total revenue driven by strong sales of its lead therapy, KIMMTRAK.
NASDAQ
X4 Pharmaceuticals reports a significant decrease in revenue and an increased net loss for Q1 2026, primarily due to the cessation of substantial upfront license revenue recognized in the prior year.
NYSE
Palmer Square Capital BDC Inc. reported a net decrease in net assets resulting from operations of $(37.2) million for the first quarter of 2026.
NYSE
TIC Solutions, Inc. reported a significant revenue increase driven by the NV5 acquisition, alongside a widened net loss and ongoing efforts to remediate internal control weaknesses.